Position in AXSM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,007,765
+$2,378,984 QoQ
Shares Held
28,630
+4.5% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#145
of 503 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Emerald Investment Advisers, LLC holds $33,887,977 across 7 Biotechnology names. AXSM ranks #2 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
46,921 | $14,831,258 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
This page
|
28,630 | $7,007,765 | |
| 3 | TARS |
Tarsus Pharmaceuticals, Inc.
|
59,747 | $3,760,476 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
131,752 | $3,333,325 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
26,459 | $2,579,223 | |
| 6 | KOD |
Kodiak Sciences Inc.
|
55,631 | $2,167,383 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
5,346 | $208,547 |
All Filings in AXSM
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,007,765 | 28,630 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,628,781 | 27,386 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||